Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros










Base de dados
Tipo de estudo
Intervalo de ano de publicação
1.
Am J Physiol Lung Cell Mol Physiol ; 280(3): L465-73, 2001 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-11159030

RESUMO

We investigated possible involvement of the actin cytoskeleton in the regulation of the L-arginine/nitric oxide (NO) pathway in pulmonary artery endothelial cells (PAEC). We exposed cultured PAEC to swinholide A (Swinh), which severs actin microfilaments, or jasplakinolide (Jasp), which stabilizes actin filaments and promotes actin polymerization, or both. After treatment, the state of the actin cytoskeleton, L-arginine uptake mediated by the cationic amino acid transporter-1 (CAT-1), Ca(2+)/calmodulin-dependent (endothelial) NO synthase (eNOS) activity and content, and NO production were examined. Jasp (50-100 nM, 2 h treatment) induced a reversible activation of L-[(3)H]arginine uptake by PAEC, whereas Swinh (10-50 nM) decreased L-[(3)H]arginine uptake. The two drugs could abrogate the effect of each other on L-[(3)H]arginine uptake. The effects of both drugs on L-[(3)H]arginine transport were not related to changes in expression of CAT-1 transporters. Swinh (50 nM, 2 h) and Jasp (100 nM, 2 h) did not change eNOS activities and contents in PAEC. Detection of NO in PAEC by the fluorescent probe 4,5-diaminofluorescein diacetate showed that Swinh (50 nM) decreased and Jasp (100 nM) increased NO production by PAEC. The stimulatory effect of Jasp on NO production was dependent on the availability of extracellular L-arginine. Our results indicate that the state of actin microfilaments in PAEC regulates L-arginine transport and that this regulation can affect NO production by PAEC.


Assuntos
Arginina/metabolismo , Citoesqueleto/fisiologia , Depsipeptídeos , Endotélio Vascular/metabolismo , Óxido Nítrico/metabolismo , Artéria Pulmonar/metabolismo , Actinas/fisiologia , Animais , Células Cultivadas , Endotélio Vascular/citologia , Toxinas Marinhas/farmacologia , Óxido Nítrico Sintase/metabolismo , Óxido Nítrico Sintase Tipo III , Peptídeos Cíclicos/farmacologia , Artéria Pulmonar/citologia , Suínos
2.
Am J Physiol Lung Cell Mol Physiol ; 278(1): L111-7, 2000 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-10645898

RESUMO

In this study, we investigated the possible interaction between the cationic amino acid transporter (CAT)-1 arginine transporter and ankyrin or fodrin. Because ankyrin and fodrin are substrates for calpain and because hypoxia increases calpain expression and activity in pulmonary artery endothelial cells (PAEC), we also studied the effect of hypoxia on ankyrin, fodrin, and CAT-1 contents in PAEC. Exposure to long-term hypoxia (24 h) inhibited L-arginine uptake by PAEC, and this inhibition was prevented by calpain inhibitor 1. The effects of hypoxia and calpain inhibitor 1 were not associated with changes in CAT-1 transporter content in PAEC plasma membranes. However, hypoxia stimulated the hydrolysis of ankyrin and fodrin in PAEC, and this could be prevented by calpain inhibitor 1. Incubation of solubilized plasma membrane proteins with anti-fodrin antibodies resulted in a 70% depletion of CAT-1 immunoreactivity and in a 60% decrease in L-arginine transport activity in reconstituted proteoliposomes (3,291 +/- 117 vs. 8,101 +/- 481 pmol. mg protein(-1). 3 min(-1) in control). Incubation with anti-ankyrin antibodies had no effect on CAT-1 content or L-arginine transport in reconstituted proteoliposomes. These results demonstrate that CAT-1 arginine transporters in PAEC are associated with fodrin, but not with ankyrin, and that long-term hypoxia decreases L-arginine transport by a calpain-mediated mechanism that may involve fodrin proteolysis.


Assuntos
Arginina/antagonistas & inibidores , Proteínas de Transporte/metabolismo , Hipóxia/metabolismo , Proteínas de Membrana/metabolismo , Proteínas dos Microfilamentos/metabolismo , Sistemas de Transporte de Aminoácidos Básicos , Animais , Anquirinas/metabolismo , Arginina/metabolismo , Calpaína/antagonistas & inibidores , Membrana Celular/metabolismo , Técnicas de Cultura , Inibidores de Cisteína Proteinase/farmacologia , Endotélio Vascular/metabolismo , Endotélio Vascular/patologia , Glicoproteínas/farmacologia , Immunoblotting , Testes de Precipitina , Artéria Pulmonar/metabolismo , Artéria Pulmonar/patologia , Valores de Referência , Suínos
3.
Biochim Biophys Acta ; 1369(1): 173-83, 1998 Feb 02.
Artigo em Inglês | MEDLINE | ID: mdl-9528685

RESUMO

We investigated the mechanisms of [3H]-L-arginine transport via System Y+ using plasma membrane vesicles derived from cultured pulmonary artery endothelial cells. [3H]-L-arginine uptake into plasma membrane vesicles was Na-independent, sensitive to trans-stimulation, unaffected by proton-conducting ionophores, and selectively inhibited by cationic amino acids. Kinetic experiments performed over a wide range of substrate concentrations revealed only one population of L-arginine transporters with Km = 130 microM. To elucidate the driving force for L-arginine transport, we measured [3H]-L-arginine uptake by plasma membrane vesicles at different transmembrane ion gradients. Plasma membrane vesicles accumulated [3H]-L-arginine only when a membrane potential was imposed across the vesicles, and the velocity of uptake was linearly related to the magnitude of the created membrane potential. The presence of potassium ions inside the vesicles was not essential for uptake of L-arginine into vesicles, but it was essential for trans-stimulation of L-arginine transport. [3H]-L-arginine accumulated in plasma membrane vesicles can be released by agents that dissipate transmembrane potassium gradients (e.g. saponin, gramicidin, and nigericin). Diazoxide and pinacidil, activators of K(+)-channels, had no significant effect on [3H]-L-arginine uptake, whereas tetraethylammonium chloride, 4-aminopyridine, and glibenclamide, inhibitors of K(+)-channels, caused decreases in [3H]-L-arginine transport by plasma membrane vesicles. This study demonstrates for the first time a specific role for potassium ions in the mechanism of L-arginine transport, particularly in the phenomenon of trans-stimulation.


Assuntos
Arginina/metabolismo , Endotélio Vascular/metabolismo , Artéria Pulmonar/metabolismo , Aminoácidos/farmacologia , Animais , Arginina/análogos & derivados , Arginina/farmacologia , Transporte Biológico , Membrana Celular/efeitos dos fármacos , Membrana Celular/metabolismo , Células Cultivadas , Endotélio Vascular/citologia , Endotélio Vascular/efeitos dos fármacos , Ionóforos/farmacologia , Cinética , Bloqueadores dos Canais de Potássio , Canais de Potássio/agonistas , Artéria Pulmonar/citologia , Sódio/metabolismo , Suínos , Trítio
4.
Am J Physiol ; 272(1 Pt 1): L78-84, 1997 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-9038906

RESUMO

System y+ accounts for the majority of L-arginine transport by pulmonary artery endothelial cells (PAEC). Given that membrane potential is a driving force for transport via system y+, we examined the hypothesis that hypoxia inhibits this transport by decreasing membrane potential. Porcine PAEC or plasma membrane vesicles derived from these cells were exposed to normoxia (room air-5% CO2) or hypoxia (0% O2-95% N2-5% CO2). After exposure, L-[3H]arginine transport and/or accumulation of the lipophilic cation [3H]tetraphenylphosphonium, a quantitative sensor of changes in cell membrane potential, were measured. Hypoxia caused reversible time-dependent decrease in L-arginine transport and membrane potential in PAEC and in plasma membrane vesicles. Comparable decreases in membrane potential and L-arginine transport by PAEC were also observed after depolarization induced by KCl or ouabain. Hyperpolarization, induced by valinomycin, increased membrane potential and L-arginine transport in PAEC and plasma membrane vesicles. Valinomycin also prevented the hypoxia-mediated decreases in membrane potential and L-arginine transport in PAEC. These results indicate that hypoxia-induced plasma membrane depolarization is responsible for reduced L-arginine transport by system y+ in hypoxic porcine PAEC.


Assuntos
Arginina/antagonistas & inibidores , Arginina/farmacocinética , Endotélio Vascular/metabolismo , Hipóxia/metabolismo , Circulação Pulmonar , Animais , Transporte Biológico/efeitos dos fármacos , Membrana Celular/metabolismo , Endotélio Vascular/patologia , Potenciais da Membrana , Oniocompostos/metabolismo , Compostos Organofosforados/metabolismo , Ouabaína/farmacologia , Potássio/farmacologia , Sódio/fisiologia , Suínos , Valinomicina/farmacologia
7.
Neirofiziologiia ; 11(6): 578-84, 1979.
Artigo em Russo | MEDLINE | ID: mdl-514416

RESUMO

Using a quantitative fluorescence-histochemical analysis the dynamics of changes of the dopamine level in dopaminergic neurons of the nigro-neostriatal and mesolimbic systems of the rat brain was studied during an hour after intraperitoneal injection of beta-phenylethylamine (100 mg/kg). The temporary increase in the dopamine level in the terminals coincided with a sharp decrease in the dopamine level in the neuron bodies, and conversely, the depletion of dopamine in the terminals after 30 min was accompanied by an increase in the dopamine level in the neuron bodies. The obtained results enable a suggestion that the increase in locomotor activity of animals after injection of beta-phenylethylamine described in the literature is due to the effect of phenylethylamine on catecholaminergic brain systems, the dopaminergic systems in particular.


Assuntos
Núcleo Caudado/efeitos dos fármacos , Dopamina/metabolismo , Núcleo Accumbens/efeitos dos fármacos , Fenetilaminas/farmacologia , Núcleos Septais/efeitos dos fármacos , Substância Negra/efeitos dos fármacos , Animais , Núcleo Caudado/metabolismo , Histocitoquímica , Masculino , Núcleo Accumbens/metabolismo , Ratos , Substância Negra/metabolismo
9.
Artigo em Russo | MEDLINE | ID: mdl-1274425

RESUMO

A study of the action of iproniaside on alimentary conditioning has shown that even its small doses (25 mg/kg) disturb the formation of the conditioned reaction, while large doses (200-250 mg/kg) do not disturb the reproduction of the conditioned reaction elaborated and stabilized before the administration of the drug. Hence, dissociated learning with the use of iproniaside is impossible. The applied doses of iproniaside result in an increased level of biogenic amines in the dopaminergic nigro-neostriate and reticulo-septal brain systems. It is therefore assumed that the effects of iproniaside on learning are due to its influence on the level of the CNS biogenic amines.


Assuntos
Aminas Biogênicas/metabolismo , Encéfalo/metabolismo , Condicionamento Clássico/efeitos dos fármacos , Isoniazida/farmacologia , Animais , Núcleo Caudado/metabolismo , Ventrículos Cerebrais/metabolismo , Masculino , Mesencéfalo/metabolismo , Ratos , Núcleos Septais/metabolismo , Substância Negra/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...